Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-23 Purchase |
2022-11-28 4:07 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
5,000 | $16.51 | $82,550 | 1,480,097 (Direct) |
View |
2021-05-25 Purchase |
2021-05-27 8:37 pm |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
17,500 | $4.1026 | $71,795 | 861,250 (Indirect Direct) |
View |
2020-06-10 Purchase |
2020-06-10 9:59 pm |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
1,000 | $31.69 | $31,690 | 1,475,097 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-12-16 Option Award |
2024-12-18 4:06 pm |
N/A 2034-12-16 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
196,000 | $0 | 196,000 (Direct) |
View |
2023-12-15 Option Award |
2023-12-19 8:00 pm |
N/A 2033-12-15 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
200,000 | $0 | 200,000 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 4:07 pm |
N/A 2032-12-09 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
250,000 | $0 | 250,000 (Direct) |
View |
2022-06-21 Option Award |
2022-06-23 4:16 pm |
N/A 2031-12-10 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO |
150,000 | $0 | 150,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-10 1:32 pm |
N/A 2032-06-09 |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
7,500 | $0 | 7,500 (Direct) |
View |
2021-05-14 Option Award |
2021-05-18 4:09 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
29,286 | $0 | 29,286 (Direct) |
View |
Ownership |
2021-02-10 08:31 am |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director 10% Owner |
0 | $0 | 843,750 (Indirect) |
View |
2020-12-18 Option Award |
2020-12-22 7:40 pm |
N/A 2030-12-18 |
Arcturus Therapeutics Holdings Inc. | ARCT | Payne Joseph E President and CEO 10% Owner |
175,000 | $0 | 175,000 (Direct) |
View |